SCHEMBL22709772

SCHEMBL22709772

CC(C)N[C@H](C=O)C(C)C

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.39
ADH1B P00325 1/20 0.36
ADH1C P00326 1/20 0.36
ADH1A P07327 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16665070 0.78 TDP1 (0.35) TDP1ADH1BADH1CADH1A
SCHEMBL22652868 0.77 TDP1 (0.39) TDP1
SCHEMBL11484246 0.76 TDP1 (0.33) TDP1ADH1BADH1CADH1A
SCHEMBL1676713 0.73
SCHEMBL6852728 0.73
SCHEMBL5695546 0.73
SCHEMBL8757885 0.71
SCHEMBL13076518 0.71
SCHEMBL13859875 0.71
SCHEMBL15896621 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020236825-A2 MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE NOVARTIS AG (CH) 2020-11-26 WO disclosed